HomeProductsBioactive CompoundsGPCR & G Protein TargetsAngiotensin ReceptorOlmesartan Medoxomil
Chemical structure of CAS 144689-63-4

Olmesartan Medoxomil

In Stock•Starting at $8 for 5 mg•Purity ≥ 98%
CAS No.144689-63-4
MDL No.MFCD00944911
MFC29H30N6O6
MW558.60
InChI KeyUQGKUQLKSCSZGY-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg98%$8In Stock
10 mg98%$9In Stock
250 mg98%$10In Stock
1 g98%$13In Stock
5 g99%$32In Stock
10 g99%$53In Stock
25 g99%$101In Stock
100 g99%$370In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Olmesartan medoxomil is a biphenyl compound.

CAS No.144689-63-4
Product NameOlmesartan Medoxomil

Biological Targets

AGTR1

Associated Conditions

glomerulonephritis·diabetic nephropathy·stroke·kidney disease·cardiovascular disease·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.

Circulation research • Vol. 88, Issue 1 • 2001
PMID: 11139469DOI: 10.1161/01.res.88.1.22

New pharmacologic aspects of CS-866, the newest angiotensin II receptor antagonist.

The American journal of cardiology • Vol. 87, Issue 8A • 2001
PMID: 11334766DOI: 10.1016/s0002-9149(01)01540-5

Clinical studies of CS-866, the newest angiotensin II receptor antagonist.

The American journal of cardiology • Vol. 87, Issue 8A • 2001
PMID: 11334767DOI: 10.1016/s0002-9149(01)01510-7

Pressure, platelets, and plaque: the central role of angiotensin II in cardiovascular pathology. Concluding comment.

The American journal of cardiology • Vol. 87, Issue 8A • 2001
PMID: 11334768DOI: 10.1016/s0002-9149(01)01547-8

Documentation

Similar Products